Researchers developed a type of nanoparticle that can “eat debris” related to the plaques that cause heart attacks.
First-time marathon runners can add years to their lives and reap the health rewards of lower blood pressure and healthier arteries, even if they take on the challenge in mid-to-later life, research showed.
Many patients with severe but stable heart disease who routinely undergo invasive procedures to clear and prop open clogged arteries would do as well by just taking medications and making lifestyle changes, U.S. researchers reported.
Pfizer’s IV Revatio, when added to inhaled nitric oxide, failed to meet the primary efficacy endpoint in treating newborns with persistent pulmonary hypertension in a Phase III study.
A new method of analyzing images from CT scans can predict which patients are at risk of a heart attack years before occurrence, researchers say.
The U.S. Food and Drug Administration approved Boston Scientific Corp.’s drug-coated stent Eluvia to treat narrowed arteries in the leg.
A Novartis anti-inflammatory drug cut cardiovascular risk for heart attack survivors in a pivotal trial, potentially changing ideas about treatment.
The U.S. Food and Drug Administration has granted priority review designation of Roche’s rheumatoid arthritis medication Actemra for giant cell arteritis (GCA).
Amgen’s Repatha with statin therapy took “bad” LDL cholesterol down to extremely low levels and caused artery-clogging plaque decline after 18 months’ treatment.
Adults with longer-lived parents have a lower-than-average risk for problems with the body’s circulatory system in middle age, British researchers have found.